SHARING IDEAS THAT DO GOOD

New drug for treating melanoma and other cancers

post-image
Researchers at the University of Colorado Cancer Centre have published their work on NLRP3 - an intracellular complex found to participate in melanoma-mediated inflammation leading to tumour growth and progression. The researchers found that by inhibiting this complex, they can reduce inflammation and tumour growth. The studies have so far used an oral NLRP3 inhibitor (Dapansutrile) which has shown to be effective in treating gout and heart disease. It is currently being tested in COVID-19.  | https://medicalxpress.com/news/2021-04-drug-tumors.html?utm_source=nwletter&utm_medium=email&utm_campaign=daily-nwletter
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Mel Raassina

9 April 2021



Related Posts

Healthcare

post-image

New generation anti-cancer drug for children with brain tumours shows promise
9 July 2021 by Mel Raassina 0 Comments

Healthcare

post-image

Faster bone repair - yes, pls
6 July 2021 by Kylie Hargrea... 0 Comments

Healthcare

post-image

Landmark DNA screening study to identify cancer risk in young adults begins
2 July 2021 by Mel Raassina 0 Comments